0.26 USD
▼-0.01-2.94%
盘后 0.29 0.00%
2026-09-16
市值
$3.89M
市盈率
—
EPS
-3.77
股息率
—
52 周区间
0.25 – 4.98
成交量
6.19M
Beta
1.45
目标价
—
52W 低 0.2552W 高 4.98
价格走势
公司简介
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies ...